{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:01:52Z","timestamp":1790874112623,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clml.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:43:54Z","timestamp":1784130234000},"page":"689-697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["KMT2A-Partial Tandem Duplication Associates With Leukemia Transformation in Myelodysplastic Syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"Zhao-Yu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-Hong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Di","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Su","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1548-0946","authenticated-orcid":false,"given":"Ya-Zhen","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clml.2026.07.008_bib0001","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41572-022-00402-5","article-title":"Myelodysplastic syndromes","volume":"8","author":"Li","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"26","key":"10.1016\/j.clml.2026.07.008_bib0002","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1182\/blood.2023020081","article-title":"The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes","volume":"142","author":"DeZern","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2026.07.008_bib0003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s40164-025-00678-9","article-title":"Advances and challenges in the treatment of myelodysplastic syndromes","volume":"14","author":"Thalla","year":"2025","journal-title":"Exp Hematol Oncol"},{"issue":"12","key":"10.1016\/j.clml.2026.07.008_bib0004","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised International prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.clml.2026.07.008_bib0005","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1038\/leu.2016.138","article-title":"Incorporation of molecular data into the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes","volume":"30","author":"Nazha","year":"2016","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.clml.2026.07.008_bib0006","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.20.01659","article-title":"Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes","volume":"39","author":"Bersanelli","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clml.2026.07.008_bib0007","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/gcc.10219","article-title":"Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia","volume":"37","author":"Steudel","year":"2003","journal-title":"Genes Chromos Cancer"},{"issue":"5","key":"10.1016\/j.clml.2026.07.008_bib0008","first-page":"774","article-title":"MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype","volume":"10","author":"Yu","year":"1996","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.clml.2026.07.008_bib0009","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3324\/haematol.10869","article-title":"A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia","volume":"92","author":"Bacher","year":"2007","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.clml.2026.07.008_bib0010","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.clml.2026.07.008_bib0011","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/ijlh.14532","article-title":"The characteristics and outcomes of adult acute myeloid leukemia patients with KMT2A-partial tandem duplication","volume":"47","author":"Xie","year":"2025","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.clml.2026.07.008_bib0012","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1182\/blood-2007-01-069831","article-title":"Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B Study","volume":"109","author":"Whitman","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2026.07.008_bib0013","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2017.185249","article-title":"Partial tandem duplication of KMT2A (MLL) may predict a subset of myelodysplastic syndrome with unique characteristics and poor outcome","volume":"103","author":"Choi","year":"2018","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.clml.2026.07.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular International Prognostic Scoring System for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid"},{"issue":"6","key":"10.1016\/j.clml.2026.07.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70406","article-title":"Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)","volume":"10","author":"Maggioni","year":"2026","journal-title":"Hemasphere"},{"key":"10.1016\/j.clml.2026.07.008_bib0016","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.20.01659","article-title":"Classification and personalized prognostic assessment on the basis of clinical and genomic features in myelodysplastic syndromes","volume":"39","author":"Bersanelli","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clml.2026.07.008_bib0017","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.clml.2026.07.008_bib0018","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2026.07.008_bib0019","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40164-022-00328-4","article-title":"IPSS-M has greater survival predictive accuracy compared with IPSS-R in persons\u2009\u2265\u200960 years with myelodysplastic syndromes","volume":"11","author":"Wu","year":"2022","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"10.1016\/j.clml.2026.07.008_bib0020","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1038\/s41375-023-01910-3","article-title":"Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes","volume":"37","author":"Aguirre","year":"2023","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.clml.2026.07.008_bib0021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1182\/blood.2019000942","article-title":"Genetics of progression from MDS to secondary leukemia","volume":"136","author":"Menssen","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2026.07.008_bib0022","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41591-018-0267-4","article-title":"Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level","volume":"25","author":"Chen","year":"2019","journal-title":"Nat Med"},{"issue":"6556","key":"10.1016\/j.clml.2026.07.008_bib0023","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/378505a0","article-title":"Altered Hox expression and segmental identity in Mll-mutant mice","volume":"378","author":"Yu","year":"1995","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.clml.2026.07.008_bib0024","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1172\/JCI25546","article-title":"Mll partial tandem duplication induces aberrant hox expression in vivo via specific epigenetic alterations","volume":"116","author":"Dorrance","year":"2006","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.clml.2026.07.008_bib0025","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1182\/blood-2012-02-412379","article-title":"Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem\/progenitor cells","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2026.07.008_bib0026","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood-2012-03-415067","article-title":"Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias","volume":"120","author":"Zorko","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2026.07.008_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2016.160","article-title":"Ordering of mutations in acute myeloid leukemia with partial tandem duplication of MLL (MLL-PTD)","volume":"31","author":"Sun","year":"2017","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.clml.2026.07.008_bib0028","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.3390\/cancers13092272","article-title":"Allogenic stem cell transplantation abrogates negative impact on outcome of AML patients with KMT2A partial tandem duplication","volume":"13","author":"Antherieu","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clml.2026.07.008_bib0029","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3324\/haematol.2023.284946","article-title":"Treatment of high-risk myelodysplastic syndromes","volume":"110","author":"Kr\u00f6ger","year":"2025","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.clml.2026.07.008_bib0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41591-021-01367-w","article-title":"Implications of allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (vol 26, pg 1549, 2020)","volume":"27","author":"Bernard","year":"2021","journal-title":"Nat Med"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026002132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265026002132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:17:13Z","timestamp":1790871433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265026002132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2152265026002132"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2026.07.008","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KMT2A-Partial Tandem Duplication Associates With Leukemia Transformation in Myelodysplastic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}